Clinical study of TMD patients treated with drug therapy in our clinic

DOI 6 Citations 9 References
  • FUJISAWA Kenji
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
  • YOKOYAMA Kazuhiro
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
  • MIYAMOTO Youji
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
  • KAMATA Nobuyuki
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
  • MAGAYAMA Masaru
    First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima

Bibliographic Information

Other Title
  • 薬物療法を行った顎関節症患者の臨床的検討

Search this article

Description

To evaluate the efficacy of drug therapy in the treatment of patients with temporomandibular disorders, we investigated clinical characteristics and treatment outcome in 180 patients with TMD treated with drug therapy in our hospital from April 1997 to March 2002. The following results were obtained.<BR>The patients were 65 males and 115 females. The largest group of patients was the 20s age group (54 cases). Thirty patients were type I, 39 patients type II, 33 patients type IIIa, 58 patients type IIIb and 19 patients type IV. One hundred and thirty-four patients came to the hospital with the chief complaint of temporomandibular joint pain and 42 patients came with the chief complaint of trismus.<BR>We treated 62 cases with only drug therapy, and 118 cases with drug therapy and other therapies. We gave only non steroidal anti-inflammatory drugs (NSAIDs) in 114 cases, only muscle relaxants in 26 cases and both of them in 36 cases. The most frequently used drugs were ampiroxicam in NSAIDs, and tolperisone hydrochloride in muscle relaxants.<BR>As for prognosis in 134 cases, 15 cases (11.2%) were completely healed, 42 cases (31.3%) were almost completely healed, 35 cases (26.1%) had some improvements in their symptom, but 42 cases (31.3%) were not improved. Better clinical outcome was obtained in patients with type I and with type II.

Journal

Citations (6)*help

See more

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top